切换至 "中华医学电子期刊资源库"

中华危重症医学杂志(电子版) ›› 2022, Vol. 15 ›› Issue (04) : 312 -317. doi: 10.3877/cma.j.issn.1674-6880.2022.04.010

荟萃分析

俯卧位通气对静脉-静脉体外膜肺氧合支持的急性呼吸窘迫综合征患者病死率影响的Meta分析
童洪杰1, 陈琨1, 潘飞艳1, 倪红英1,()   
  1. 1. 321000 浙江金华,浙江大学医学院附属金华医院重症医学科
  • 收稿日期:2022-02-09 出版日期:2022-08-31
  • 通信作者: 倪红英
  • 基金资助:
    金华市科学技术局新型冠状病毒感染肺炎疫情应急防治科研攻关项目(2020XG-03)

Effect of prone position ventilation on mortality in patients with acute respiratory distress syndrome supported by veno-venous extracorporeal membrane oxygenation: a meta-analysis

Hongjie Tong1, Kun Chen1, Feiyan Pan1, Hongying Ni1,()   

  1. 1. Department of Intensive Care Medicine, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua 321000, China
  • Received:2022-02-09 Published:2022-08-31
  • Corresponding author: Hongying Ni
引用本文:

童洪杰, 陈琨, 潘飞艳, 倪红英. 俯卧位通气对静脉-静脉体外膜肺氧合支持的急性呼吸窘迫综合征患者病死率影响的Meta分析[J/OL]. 中华危重症医学杂志(电子版), 2022, 15(04): 312-317.

Hongjie Tong, Kun Chen, Feiyan Pan, Hongying Ni. Effect of prone position ventilation on mortality in patients with acute respiratory distress syndrome supported by veno-venous extracorporeal membrane oxygenation: a meta-analysis[J/OL]. Chinese Journal of Critical Care Medicine(Electronic Edition), 2022, 15(04): 312-317.

目的

系统评价俯卧位通气对静脉-静脉体外膜肺氧合(VV-ECMO)支持的急性呼吸窘迫综合征(ARDS)患者病死率的影响。

方法

计算机检索Medline、荷兰医学文摘Embase、Cochrane临床试验数据库、万方数据库及中国知网数据库从2002年1月至2022年1月关于VV-ECMO支持ARDS期间使用俯卧位通气的随机对照研究或观察性研究。试验组为俯卧位通气患者,对照组为仰卧位通气患者。由2名研究人员独立进行筛选文献、提取文献资料及评估方法学质量后,采用RevMan 5.3软件进行Meta分析。

结果

最终纳入14项研究,共计1 880例患者,其中试验组869例,对照组1 011例。Meta分析显示,与对照组比较,试验组VV-ECMO支持的ARDS患者的28 d病死率[相对危险度(RR)=0.59,95%置信区间(CI)(0.43,0.80),Z = 3.41,P = 0.000 7]及住院病死率[RR = 0.73,95%CI(0.66,0.81),Z = 5.86,P < 0.000 01]均显著降低;但两组患者间其他病死率(30 d、60 d、90 d、ICU、6个月病死率)的比较,差异无统计学意义[RR = 0.80,95%CI(0.61,1.05),Z = 1.60,P = 0.11]。

结论

俯卧位通气能够降低VV-ECMO支持的ARDS患者28 d病死率以及住院病死率。

Objective

To systematically evaluate the effect of prone position ventilation on mortality in patients with acute respiratory distress syndrome (ARDS) supported by veno-venous extracorporeal membrane oxygenation (VV-ECMO).

Methods

Randomized controlled studies or observational studies concerning prone position ventilation for ARDS patients supported by VV-ECMO published from January 2002 to January 2022 in Medline, Embase, Cochrane Library, Wangfang and CNKI databases were searched comprehensively and systematically. Two reviewers independently screened articles, extracted data and evaluated methodological quality. Then meta-analysis was performed using the RevMan 5.3.

Results

A total of 14 articles with 1 880 patients were enrolled in this study, 869 patients in the experimental group (prone position ventilation) and 1 011 patients in the control group (supine position ventilation). Meta-analysis showed that the 28-day mortality [relative risk (RR) = 0.59, 95% confidence interval (CI) (0.43, 0.80), Z = 3.41, P = 0.000 7] and in-hospital mortality [RR = 0.73, 95%CI (0.66, 0.81), Z = 5.86,P < 0.000 01] in the experimental group were much lower than those in the control group. However, the other mortality (30-day, 60-day, 90-day, ICU and 6-month mortality) was not significantly different between the two groups [RR = 0.80, 95%CI (0.61, 1.05), Z = 1.60, P = 0.11].

Conclusion

Prone position ventilation can reduce the 28-day mortality and in-hospital mortality in ARDS patients supported by VV-ECMO.

表1 纳入文献的临床资料与Grade分级情况
图1 两种通气方法对VV-ECMO支持的ARDS患者28 d病死率影响的森林图注:VV-ECMO.静脉-静脉体外膜肺氧合;ARDS.急性呼吸窘迫综合征;试验组为俯卧位通气患者,对照组为仰卧位通气患者;RR.相对危险度;CI.置信区间
图2 两种通气方法对VV-ECMO支持的ARDS患者住院病死率影响的森林图注:VV-ECMO.静脉-静脉体外膜肺氧合;ARDS.急性呼吸窘迫综合征;试验组为俯卧位通气患者,对照组为仰卧位通气患者;RR.相对危险度;CI.置信区间
图3 两种通气方法对VV-ECMO支持的ARDS患者其它病死率影响的森林图注:VV-ECMO.静脉-静脉体外膜肺氧合;ARDS.急性呼吸窘迫综合征;试验组为俯卧位通气患者,对照组为仰卧位通气患者;RR.相对危险度;CI.置信区间
1
杨茂宪,姚明,徐龙生,等.姜黄素对急性呼吸窘迫综合征大鼠肺组织及气道重塑的影响[J/CD].中华危重症医学杂志(电子版)202114(5):368-373.
2
Combes A, Peek GJ, Hajage D, et al. ECMO for severe ARDS: systematic review and individual patient data meta-analysis[J]. Intensive Care Med, 2020, 46 (11): 2048-57.
3
岳伟岗,向飞,张莹,等.急性呼吸窘迫综合征患者早期应用气道压力释放通气的疗效[J/CD].中华危重症医学杂志(电子版)202013(2):93-99.
4
Scholten EL, Beitler JR, Prisk GK, et al. Treatment of ARDS with prone positioning[J]. Chest, 2017, 151 (1): 215-224.
5
Guervilly C, Prud'homme E, Pauly V, et al. Prone positioning and extracorporeal membrane oxygenation for severe acute respiratory distress syndrome: time for a randomized trial?[J]. Intensive Care Med, 2019, 45 (7): 1040-1042.
6
Shekar K, Ramanathan K, Brodie D. Prone positioning of patients during venovenous extracorporeal membrane oxygenation[J]. Ann Am Thorac Soc, 2021, 18 (3): 421-423.
7
Rilinger J, Zotzmann V, Bemtgen X, et al. Prone positioning in severe ARDS requiring extracorporeal membrane oxygenation[J]. Crit Care, 2020, 24 (1): 397.
8
Garcia B, Cousin N, Bourel C, et al. Prone positioning under VV-ECMO in SARS-CoV-2-induced acute respiratory distress syndrome[J]. Crit Care, 2020, 24 (1): 428.
9
Kimmoun A, Roche S, Bridey C, et al. Prolonged prone positioning under VV-ECMO is safe and improves oxygenation and respiratory compliance[J]. Ann Intensive Care, 2015, 5 (1): 35.
10
Giani M, Martucci G, Madotto F, et al. Prone positioning during venovenous extracorporeal membrane oxygenation in acute respiratory distress syndrome. A multicenter cohort study and propensity-matched analysis[J]. Ann Am Thorac Soc, 2021, 18 (3): 495-501.
11
Chaplin H, McGuinness S, Parke R. A single-centre study of safety and efficacy of prone positioning for critically ill patients on veno-venous extracorporeal membrane oxygenation[J]. Aust Crit Care, 2021, 34 (5): 446-451.
12
Combes A, Hajage D, Capellier G, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome[J]. N Engl J Med, 2018, 378 (21): 1965-1975.
13
Jozwiak M, Chiche JD, Charpentier J, et al. Use of venovenous extracorporeal membrane oxygenation in critically-ill patients with COVID-19[J]. Front Med (Lausanne), 2020 (7): 614569.
14
Le Breton C, Besset S, Freita-Ramos S, et al. Extracorporeal membrane oxygenation for refractory COVID-19 acute respiratory distress syndrome[J]. J Crit Care, 2020 (60): 10-12.
15
Lebreton G, Schmidt M, Ponnaiah M, et al. Extracorporeal membrane oxygenation network organisation and clinical outcomes during the COVID-19 pandemic in Greater Paris, France: a multicentre cohort study[J]. Lancet Respir Med, 2021, 9 (8): 851-862.
16
Petit M, Fetita C, Gaudemer A, et al. Prone-positioning for severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation[J]. Crit Care Med, 2022, 50 (2): 264-274.
17
Schmidt M, Hajage D, Lebreton G, et al. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study[J]. Lancet Respir Med, 2020, 8 (11): 1121-1131.
18
Yang X, Hu M, Yu Y, et al. Extracorporeal membrane oxygenation for SARS-CoV-2 acute respiratory distress syndrome: a retrospective study from Hubei, China[J]. Front Med (Lausanne), 2021 (7): 611460.
19
COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4 244 critically ill adults with COVID-19: a prospective cohort study[J]. Intensive Care Med, 2021, 47 (1): 60-73.
20
Gattinoni L, Busana M, Giosa L, et al. Prone positioning in acute respiratory distress syndrome[J]. Semin Respir Crit Care Med, 2019, 40 (1): 94-100.
21
Ding L, Wang L, Ma W, et al. Efficacy and safety of early prone positioning combined with HFNC or NIV in moderate to severe ARDS: a multi-center prospective cohort study[J]. Crit Care, 2020, 24 (1): 28.
22
Hadaya J, Benharash P. Prone positioning for acute respiratory distress syndrome (ARDS)[J]. JAMA, 2020, 324 (13): 1361.
23
Liu X, Liu H, Lan Q, et al. Early prone positioning therapy for patients with mild COVID-19 disease[J]. Med Clin (Barc), 2021, 156 (8): 386-389.
24
Guérin C, Albert RK, Beitler J, et al. Prone position in ARDS patients: why, when, how and for whom[J]. Intensive Care Med, 2020, 46 (12): 2385-2396.
25
Kim WY, Kang BJ, Chung CR, et al. Prone positioning before extracorporeal membrane oxygenation for severe acute respiratory distress syndrome: a retrospective multicenter study[J]. Med Intensiva (Engl Ed), 2019, 43 (7): 402-409.
[1] 蚁淳, 袁冬生, 熊学军. 系统免疫炎症指数与骨密度降低和骨质疏松的关联[J/OL]. 中华关节外科杂志(电子版), 2024, 18(05): 609-617.
[2] 李志文, 李远志, 李华, 方志远. 糖皮质激素治疗膝骨关节炎疗效的网状Meta分析[J/OL]. 中华关节外科杂志(电子版), 2024, 18(04): 484-496.
[3] 江雅婷, 刘林峰, 沈辰曦, 陈奔, 刘婷, 龚裕强. 组织相关巨噬素3 保护肺血管内皮糖萼治疗急性呼吸窘迫综合征的机制研究[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(05): 353-362.
[4] 李振翮, 魏长青, 甄国栋, 李振富. 脓毒症并发急性呼吸窘迫综合征患者血清S1P、Wnt5a变化及其临床意义[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 293-300.
[5] 吴姗姗, 潘裕民, 刘晋, 张劲松, 乔莉. 睡眠呼吸暂停综合征患者静脉血栓栓塞症发生率的Meta分析[J/OL]. 中华危重症医学杂志(电子版), 2024, 17(04): 312-317.
[6] 奚卫, 王闻卿, 刘玥, 王亚楠, 许学斌. 胃肠炎继发脓毒症感染创伤弧菌ST14514的病原学诊断与文献病例回顾分析[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(05): 293-302.
[7] 李智, 冯芸. NF-κB 与MAPK 信号通路及其潜在治疗靶点在急性呼吸窘迫综合征中的研究进展[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(05): 840-843.
[8] 马振威, 宋润夫, 王兵. ERCP胆道内支架与骑跨十二指肠乳头支架置入治疗不可切除肝门部胆管癌疗效的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(06): 807-812.
[9] 龚财芳, 赵俊宇, 游川. 围手术期肠内营养在肝癌肝切除患者中有效性及安全性的Meta分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(04): 551-556.
[10] 王芳, 刘达, 左智炜, 盛金平, 陈庭进, 蒋锐. 定量CT与双能X线骨密度仪对骨质疏松诊断效能比较的Meta分析[J/OL]. 中华老年骨科与康复电子杂志, 2024, 10(06): 363-371.
[11] 王晓霞, 乌丹, 张江英, 乌雅罕, 郝颖楠, 斯日古楞. 《2023 年美国胸科学会关于成人急性呼吸窘迫综合征患者管理的临床实践指南更新》解读[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 338-343.
[12] 李茂军, 唐彬秩, 吴青, 阳倩, 梁小明, 邹福兰, 黄蓉, 陈昌辉. 新生儿呼吸窘迫综合征的管理:多国指南/共识及RDS-NExT workshop 共识陈述简介和评价[J/OL]. 中华临床医师杂志(电子版), 2024, 18(07): 607-617.
[13] 周倩妹, 王宪娥, 徐筱, 老慧琳, 赵欣悦, 胡菁颖. 多元化系统护理对老年人群牙周健康指标影响的系统评价[J/OL]. 中华临床医师杂志(电子版), 2024, 18(05): 500-506.
[14] 李文哲, 王毅, 崔建, 郑启航, 王靖彦, 于湘友. 新疆维吾尔自治区重症患者急性肾功能异常的危险因素分析[J/OL]. 中华卫生应急电子杂志, 2024, 10(05): 269-276.
[15] 刘晴雯, 韩勇, 陈丽丹, 邓哲. 早期机械通气对成人院内心脏骤停病死率的影响:一项回顾性队列研究[J/OL]. 中华卫生应急电子杂志, 2024, 10(04): 203-206.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?